Minneapolis
89°F
eEdition
News & Politics
Sports
Food & Culture
Business
Outdoors
Opinion
Things To Do
Obituaries
More of What Matters to Minnesota
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Minnesota State Top Stocks
Markets
Minnesota Stocks
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Organon & Co.
(NY:
OGN
)
23.03
+0.67 (+3.00%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Organon & Co.
< Previous
1
2
3
4
5
6
7
8
9
Next >
Organon and Cirqle Biomedical Enter Research Collaboration and License Agreement for Investigational Non-hormonal, On-demand Contraceptive Candidate
July 28, 2022
From
Organon & Co.
Via
Business Wire
Organon To Report Second Quarter Results and Host Conference Call on August 4, 2022
July 21, 2022
From
Organon & Co.
Via
Business Wire
Week In Review: Joincare Plans $300-$400 Million IPO On Swiss Exchange
June 18, 2022
Joincare Pharmaceutical of Shenzhen plans to list on the SIX Swiss stock exchange, an unusual venue for a China biopharma. The company said it aims to broaden its financing sources and increase global...
Via
Talk Markets
Organon Enters into Global License Agreement to Commercialize Henlius’ Investigational Perjeta® (Pertuzumab) and Prolia®/Xgeva® (Denosumab) Biosimilar Candidates
June 13, 2022
From
Organon & Co.
Via
Business Wire
Amphastar's Generic Ganirelix Acetate Injection Scores FDA Approval
April 08, 2022
Via
Benzinga
Merck Spinoff Organon Beats Quarterly Views, But Offers Dim Guidance
February 17, 2022
Organon's sales and earnings fell less than expected, but 2022 sales guidance missed.
Via
Investor's Business Daily
On One Year Anniversary, Organon Introduces Global ESG Strategy and Commitments with Publication of Inaugural ESG Report
June 02, 2022
From
Organon & Co.
Via
Business Wire
Market Selloff
May 10, 2022
In a U.S. market selloff, the strong performance of mostly foreign issues was impressive.
Via
Talk Markets
Organon Easily Beats First-Quarter Expectations Despite Nexplanon Slip-Up
May 05, 2022
The firm's biggest product sustained a hit due to exchange rates and buying patterns.
Via
Investor's Business Daily
Organon Reports Results for the First Quarter Ended March 31, 2022
May 05, 2022
From
Organon & Co.
Via
Business Wire
Earnings Scheduled For February 17, 2022
February 17, 2022
Companies Reporting Before The Bell • Palantir Technologies (NYSE:PLTR) is estimated to report quarterly earnings at $0.04 per share on revenue of $417.69 million.
Via
Benzinga
Organon To Report First Quarter Results and Host Conference Call on May 5, 2022
April 21, 2022
From
Organon & Co.
Via
Business Wire
Organon Inks Licensing Pact For Daré Bioscience's Bacterial Vaginosis Treatment
March 31, 2022
Organon & Co (NYSE: OGN)
Via
Benzinga
Organon Enters into Global License Agreement to Commercialize Daré Bioscience’s XACIATO™ (clindamycin phosphate vaginal gel, 2%), FDA-Approved Treatment for Females 12 and Older with Bacterial Vaginosis (BV)
March 31, 2022
From
Organon & Co.
Via
Business Wire
Healthy Pharma Favorites
March 25, 2022
Here's a look at two drug makers that we recommend in our Growth & Income Portfolio. The stocks in this portfolio are generally higher-quality, larger-cap companies that have fallen out of favor.
Via
Talk Markets
AbbVie, Alvotech Resolve US Patent Dispute Related To Humira Biosimilar
March 09, 2022
Alvotech Holdings S.A. has entered into a settlement agreement with AbbVie Inc (NYSE: ABBV), allowing Alvotech to market AVT02 (100 mg/mL), its high-...
Via
Benzinga
Overview Of Value Stocks In The Healthcare Sector
February 21, 2022
What Defines a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...
Via
Benzinga
World Markets News For Thursday
February 17, 2022
Ericsson stock lost another 5.27% today in US markets.
Via
Talk Markets
Established Brands Hit Organon's Q4 Sales, Expects FY22 Sales Of Upto $6.4B
February 17, 2022
Organon & Co's (NYSE: OGN) Q4 FY21 sales decreased 1% to $1.6 billion, beating the consensus of $1.57 billion. Women's Health increased 6%, driven primarily...
Via
Benzinga
Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2021
February 17, 2022
From
Organon & Co.
Via
Business Wire
Organon Acquires Contraceptive Products, Marvelon® and Mercilon®, in the People’s Republic of China, including Hong Kong and Macau, and Agrees to Acquire these Products in Vietnam
February 16, 2022
From
Organon & Co.
Via
Business Wire
Nuclear Winter
February 11, 2022
Mexico is raising interest rates to 6%, from 5.5%.
Via
Talk Markets
Organon antaa koko henkilökunnalleen vapaapäivän oman terveytensä edistämiseksi kansainvälisenä naisten päivänä
February 10, 2022
”Koska Covid-19-pandemialla on edelleen suhteettoman suuri vaikutus naisiin, Organon kutsuu muita organisaatioita liittymään joukkoonsa ja olemaan
Via
EIN Presswire
Organon Declares Paid Time Off for All Employees on International Women’s Day; Employees to Focus on Their Own Health in Recognition of Growing Women’s Health Inequity
February 02, 2022
From
Organon & Co.
Via
Business Wire
Organon To Report Fourth Quarter and Full Year Results and Host Conference Call on February 17, 2022
February 01, 2022
From
Organon & Co.
Via
Business Wire
FDA Accepts Samsung Bioepis’ and Organon’s sBLA for their Citrate-Free, High-Concentration HUMIRA® (Adalimumab) Biosimilar Candidate
January 05, 2022
From
Organon & Co.
Via
Business Wire
Organon To Present at the 40th Annual J.P. Morgan Healthcare Virtual Conference
December 20, 2021
From
Organon & Co.
Via
Business Wire
Organon Completes Acquisition of Forendo Pharma
December 13, 2021
From
Organon & Co.
Via
Business Wire
Warren Buffett Is Selling These Stocks
November 30, 2021
Looking to make money moves like Warren Buffett? Want to know which stocks Buffett is selling? Interested in finding out why these stock sales might be a huge mistake?
Via
Talk Markets
Tuesday Markets Coverage
November 23, 2021
GE was up on hopes for cheaper oil. But most stocks were down on oil price hike fears.
Via
Talk Markets
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.